Clinical Trial Results - Progress in Cancer Care
These summaries highlight recently released results from cancer clinical trials. The findings are significant enough that they are likely to influence your medical care.
The summaries are listed in reverse chronological order. You may also use the navigation tools on the left to search the summaries by keyword or type of cancer.
16. Docetaxel (Taxotere®) Before Radiation Extends Survival in Patients with Head and Neck Cancer
(Posted: 06/05/2004) - In a phase III study of patients with inoperable head and neck cancer, a multidrug chemotherapy regimen including the drug docetaxel (Taxotere®) that was given before radiation extended patients' survival by about four months, with fewer side effects, compared to standard therapy.
17. Post-Surgery Chemotherapy Improves Survival in Early Lung Cancer
(Posted: 06/05/2004) - Two large randomized studies show that in early-stage non-small cell lung cancer, treatment after surgery with chemotherapy improves overall survival compared to surgery alone. The findings help resolve a controversy over the value of post-surgical chemotherapy for early lung cancer and are likely to change the standard of care.
18. Combined Therapy May Offer Advantage in Head and Neck Cancer
(Posted: 06/02/2004) - Patients with head and neck cancer who were treated with chemotherapy in addition to radiation after surgery had fewer recurrences of disease and longer disease-free survival than patients who were treated with radiation alone after surgery, two randomized clinical trials have found.
19. Laparoscopic Surgery a Good Alternative for Some Colon Cancer Patients
(Posted: 06/02/2004) - Patients with colon cancer experienced similar rates of cancer recurrence whether they were treated with laparoscopically assisted surgery or conventional open abdominal surgery (colectomy) in a large randomized clinical trial.
20. Some Men with Low PSAs Have Prostate Cancer
(Posted: 05/26/2004) - Men with low PSA (prostate specific antigen) levels on screening tests can still have prostate cancer, according to a study released today by scientists from the National Cancer Institute (NCI), part of the National Institutes of Health, and the Southwest Oncology Group, an NCI-funded network of researchers.
< Previous 1 2 3 4 5 6 7 Next >
|
